Arrowstreet Capital Limited Partnership Purchases 77,393 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Arrowstreet Capital Limited Partnership grew its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 79.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 174,916 shares of the specialty pharmaceutical company’s stock after acquiring an additional 77,393 shares during the quarter. Arrowstreet Capital Limited […]

Leave a Reply

Your email address will not be published.

Previous post Arrowstreet Capital Limited Partnership Grows Stake in Korea Electric Power Co. (NYSE:KEP)
Next post California Public Employees Retirement System Has $8.31 Million Holdings in Independence Realty Trust, Inc. (NYSE:IRT)